JP2005519073A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005519073A5 JP2005519073A5 JP2003567333A JP2003567333A JP2005519073A5 JP 2005519073 A5 JP2005519073 A5 JP 2005519073A5 JP 2003567333 A JP2003567333 A JP 2003567333A JP 2003567333 A JP2003567333 A JP 2003567333A JP 2005519073 A5 JP2005519073 A5 JP 2005519073A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- compound
- group
- metabolite
- sleep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 claims 14
- 125000001424 substituent group Chemical group 0.000 claims 6
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 4
- 239000002207 metabolite Substances 0.000 claims 4
- 239000000203 mixture Substances 0.000 claims 4
- 125000006850 spacer group Chemical group 0.000 claims 4
- 230000005856 abnormality Effects 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 230000002060 circadian Effects 0.000 claims 2
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 125000004185 ester group Chemical group 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- -1 modified trazodone compound Chemical class 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 208000019116 sleep disease Diseases 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- LKKWNBWRPDKMIB-UHFFFAOYSA-N 3-chloro-1-phenylpiperazine Chemical compound C1CNC(Cl)CN1C1=CC=CC=C1 LKKWNBWRPDKMIB-UHFFFAOYSA-N 0.000 claims 1
- 206010000117 Abnormal behaviour Diseases 0.000 claims 1
- 239000004215 Carbon black (E152) Substances 0.000 claims 1
- 208000019888 Circadian rhythm sleep disease Diseases 0.000 claims 1
- 206010010904 Convulsion Diseases 0.000 claims 1
- 208000007590 Disorders of Excessive Somnolence Diseases 0.000 claims 1
- 208000001456 Jet Lag Syndrome Diseases 0.000 claims 1
- 208000005793 Restless legs syndrome Diseases 0.000 claims 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 229930195733 hydrocarbon Natural products 0.000 claims 1
- 150000002430 hydrocarbons Chemical class 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 206010020765 hypersomnia Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 206010022437 insomnia Diseases 0.000 claims 1
- 208000033915 jet lag type circadian rhythm sleep disease Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- YZTJYBJCZXZGCT-UHFFFAOYSA-N phenylpiperazine Chemical class C1CNCCN1C1=CC=CC=C1 YZTJYBJCZXZGCT-UHFFFAOYSA-N 0.000 claims 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 208000033914 shift work type circadian rhythm sleep disease Diseases 0.000 claims 1
- 201000002859 sleep apnea Diseases 0.000 claims 1
- 208000020685 sleep-wake disease Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical group FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 claims 1
- 150000007970 thio esters Chemical group 0.000 claims 1
- PHLBKPHSAVXXEF-UHFFFAOYSA-N trazodone Chemical class ClC1=CC=CC(N2CCN(CCCN3C(N4C=CC=CC4=N3)=O)CC2)=C1 PHLBKPHSAVXXEF-UHFFFAOYSA-N 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34991202P | 2002-01-18 | 2002-01-18 | |
| US35732002P | 2002-02-15 | 2002-02-15 | |
| PCT/US2003/001845 WO2003068148A2 (en) | 2002-01-18 | 2003-01-21 | Treatment of sleep disorders using sleep target modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005519073A JP2005519073A (ja) | 2005-06-30 |
| JP2005519073A5 true JP2005519073A5 (enExample) | 2005-12-22 |
Family
ID=27737408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003567333A Withdrawn JP2005519073A (ja) | 2002-01-18 | 2003-01-21 | 睡眠標的モジュレーターを使用する睡眠障害の治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20060009465A1 (enExample) |
| EP (1) | EP1471913A2 (enExample) |
| JP (1) | JP2005519073A (enExample) |
| AU (1) | AU2003210598A1 (enExample) |
| CA (1) | CA2473586A1 (enExample) |
| WO (1) | WO2003068148A2 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY28538A1 (es) * | 2003-09-26 | 2005-04-29 | Vertex Pharma | Derivados de fenil-piperazina como moduladores de receptores muscarínicos |
| WO2005107700A2 (en) * | 2004-04-26 | 2005-11-17 | Immuneregen Biosciences, Inc. | Anti-aging effects of substance p |
| JP4613031B2 (ja) * | 2004-05-06 | 2011-01-12 | エスエス製薬株式会社 | 催眠剤組成物 |
| DK1931346T3 (da) * | 2005-09-09 | 2012-10-22 | Angelini Labopharm Llc | Trazodonsammensætning til indgivelse en gang om dagen |
| CN101242856A (zh) * | 2005-09-09 | 2008-08-13 | 莱博法姆公司 | 持续药物释放的组合物 |
| WO2007098202A2 (en) | 2006-02-16 | 2007-08-30 | Imthera Medical, Inc. | An rfid based apparatus, system, and method for therapeutic treatment of a patient |
| WO2008070795A2 (en) * | 2006-12-06 | 2008-06-12 | Somaxon Pharmaceuticals, Inc. | Combination therapy using low-dose doxepin for the improvement of sleep |
| JP2011500143A (ja) | 2007-10-09 | 2011-01-06 | イムセラ・メディカル・インコーポレーテッド | 選択的刺激のための装置、システム、及び方法 |
| CA2738479C (en) | 2008-10-09 | 2017-11-28 | Imthera Medical, Inc. | Method of stimulating a hypoglossal nerve for controlling the position of a patient's tongue |
| PT2314182E (pt) † | 2009-10-23 | 2011-10-17 | Gruppo Cimbali Spa | Máquina de café com regulação de pressão de distribuição e um método correspondente |
| AU2010318651A1 (en) | 2009-11-10 | 2012-05-03 | Imthera Medical, Inc. | System for stimulating a hypoglossal nerve for controlling the position of a patient's tongue |
| WO2012103411A2 (en) | 2011-01-28 | 2012-08-02 | Zx Pharma, Llc | Controlled-release melatonin composition and related methods |
| US9532952B2 (en) | 2011-01-28 | 2017-01-03 | Physician's Seal, LLC | Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients |
| ES2673286T3 (es) | 2011-02-11 | 2018-06-21 | Zx Pharma, Llc | Formulaciones multiparticuladas de L-mentol y métodos relacionados |
| US8911780B2 (en) | 2011-02-11 | 2014-12-16 | Zx Pharma, Llc | Multiparticulate L-menthol formulations and related methods |
| US8808736B2 (en) | 2011-02-11 | 2014-08-19 | Zx Pharma, Llc | Enteric coated multiparticulate controlled release peppermint oil composition and related methods |
| US20120315337A1 (en) * | 2011-06-07 | 2012-12-13 | Shah Syed | Multiparticulate 5-htp compositions and related methods |
| US9266881B2 (en) | 2011-11-14 | 2016-02-23 | Merck Sharp & Dohme Corp. | Triazolopyridinone PDE10 inhibitors |
| SMT201900021T1 (it) | 2013-04-23 | 2019-02-28 | Zx Pharma Llc | Composizione gastroresistente a base di multiparticolato con sottorivestimento proteinaceo |
| CN107635549A (zh) | 2015-03-26 | 2018-01-26 | 杰奎琳·M·艾弗森 | 抑制与宿醉相关的症状的方法和组合物 |
| WO2019192903A1 (de) * | 2018-04-06 | 2019-10-10 | Basf Se | Verfahren zur herstellung von aminen |
| JP2025539064A (ja) * | 2022-11-11 | 2025-12-03 | ギルガメッシュ・ファーマシューティカルズ・インコーポレイテッド | トラゾドンを使用して5-ht2a受容体アゴニストの効果を逆転させる方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5116852A (en) * | 1990-12-03 | 1992-05-26 | Bristol-Myers Squibb Co. | Treatment of sleep disorders |
-
2003
- 2003-01-21 US US10/501,855 patent/US20060009465A1/en not_active Abandoned
- 2003-01-21 WO PCT/US2003/001845 patent/WO2003068148A2/en not_active Ceased
- 2003-01-21 EP EP03739676A patent/EP1471913A2/en not_active Withdrawn
- 2003-01-21 US US10/349,164 patent/US20030232839A1/en not_active Abandoned
- 2003-01-21 AU AU2003210598A patent/AU2003210598A1/en not_active Abandoned
- 2003-01-21 CA CA002473586A patent/CA2473586A1/en not_active Abandoned
- 2003-01-21 JP JP2003567333A patent/JP2005519073A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005519073A5 (enExample) | ||
| JP2024050527A5 (enExample) | ||
| JP2010523476A5 (enExample) | ||
| JP2011515482A5 (enExample) | ||
| JP2014051526A5 (enExample) | ||
| JP2009143956A5 (enExample) | ||
| JP2018135343A5 (enExample) | ||
| JP2011519854A5 (enExample) | ||
| JP2014507455A5 (enExample) | ||
| JP2014508811A5 (enExample) | ||
| JP2009531277A5 (enExample) | ||
| JP2007508361A5 (enExample) | ||
| ME02766B (me) | Derivati arilmetoksi izoindolina i kompozicije koje ih obuhvataju i postupci njihove primene | |
| JP2010503688A5 (enExample) | ||
| JP2005508349A5 (enExample) | ||
| JP2004525117A5 (enExample) | ||
| ME01421B (me) | 5-supstituisani derivati kinazolinona kao protivtumorska sredstva | |
| JP2007523155A5 (enExample) | ||
| JP2013537203A5 (enExample) | ||
| JP2014506907A5 (enExample) | ||
| JP2007508360A5 (enExample) | ||
| JP2019519587A5 (enExample) | ||
| JP2015517555A5 (enExample) | ||
| JP2005539045A5 (enExample) | ||
| JP2007534702A5 (enExample) |